Latest filing published 13 Mar 2020 for GYRE THERAPEUTICS, INC., €7,349.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +61.1%Entry US$55.50 · Close at T+365 US$89.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Veronica Cai: trading record in brief
This profile gathers the share dealings of Veronica Cai in Gyre Therapeutics, Inc. Between 10 February 2020 and 13 March 2020, the trades on record add up to 2 filings.
The open-market record is one-sided, with 1 purchase worth €7,349 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.
On 13 March 2020 came the latest disclosure, an open-market purchase for €7,349 in Gyre Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Veronica Cai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$4.1143.5% of flowCommon StockSEC:0001209191-20-019037:0Canonical exit: 11 Jun 2020 (T+90)
- 1,678 shares@ US$6.2356.5% of flowCommon StockSEC:0001209191-20-009039:0
2 of 2 declarations
